ChEMBL
Chemical database of bioactive molecules also having drug-like properties / From Wikipedia, the free encyclopedia
ChEMBL or ChEMBLdb is a manually curated chemical database of bioactive molecules with drug inducing properties.[1] It is maintained by the European Bioinformatics Institute (EBI), of the European Molecular Biology Laboratory (EMBL), based at the Wellcome Trust Genome Campus, Hinxton, UK.
Quick Facts Content, Description ...
Content | |
---|---|
Description | Biological database |
Data types captured | Molecules with drug-like properties and biological activity |
Contact | |
Research center | European Molecular Biology Laboratory |
Laboratory | European Bioinformatics Institute |
Authors | Andrew Leach, Team Leader 2016-Present; John Overington, Team Leader 2008-2015 |
Primary citation | PMID 21948594 |
Release date | 2009 |
Access | |
Website | ChEMBL |
Download URL | Downloads |
Web service URL | ChEMBL Webservices |
Sparql endpoint | ChEMBL EBI-RDF Platform |
Miscellaneous | |
License | The ChEMBL data is made available on a Creative Commons Attribution-Share Alike 3.0 Unported Licence |
Versioning | ChEMBL_28 |
Close
The database, originally known as StARlite, was developed by a biotechnology company called Inpharmatica Ltd. later acquired by Galapagos NV. The data was acquired for EMBL in 2008 with an award from The Wellcome Trust,[2] resulting in the creation of the ChEMBL chemogenomics group at EMBL-EBI, led by John Overington.[3][4]